Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same

Abstract: The present invention relates generally to the modulation of hyaluronan (HA) synthesis and degradation. More particularly, the present invention provides compositions and methods for modulating the expression of genetic material encoding HA synthase (HAS) and other enzymes or receptors primarily involved in hyaluronan metabolism; or modulating the proteins that synthesise ...






Agent: Alchemia Oncology Pty Limited - Eight Mile Plains, AUInventors: Tracey J. Brown, Gary R.

Read more ...